Since there is increasing evidence of the association between insulin resistance and neurodegenerative disease, the role of IGF-II, which has a higher affinity than IGF-I for IRA/IGF1R hybrids [125] and interacts with IGF2R, including its soluble form, is recommended as a research focus. The gene discussed is IGF2; the disease is neurodegenerative disease.